Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 30
Filter
5.
Rev. cuba. hematol. inmunol. hemoter ; 33(3): 95-101, jul.-set. 2017. ilus, tab
Article in Spanish | LILACS | ID: biblio-960425

ABSTRACT

Las leucemias agudas representan un grupo heterogéneo de hemopatías malignas que pueden ser de origen linfoide o mieloide en dependencia del clon celular que da lugar al proceso maligno. Sin embargo, existen casos de leucemias agudas con fenotipo mixto donde coexisten características propias de más de un linaje celular y que se conocen hoy como leucemias agudas de fenotipo mixto. Se presenta el caso de un paciente que se diagnosticó como una leucemia aguda híbrida linfoide B/mieloide mediante citometría de flujo. Se encontró la presencia del gen de fusión E2A-PBX1 que se forma como consecuencia de una traslocación entre los cromosomas 1 y 19. El paciente, un niño de 20 meses de nacido, falleció a los 12 días de iniciados los primeros síntomas clínicos. Se conoce que esta anormalidad cromosómica está asociada a un pronóstico desfavorable, principalmente por la grave afectación del sistema nervioso central como en efecto ocurrió. Hasta donde se alcanzó a revisar, no se encontró un reporte similar en la literatura de una leucemia aguda híbrida linfoide B/mieloide positiva al gen defusión E2A-PBX1(AU)


The acute leukemias are an heterogenous group of malignant hemopathies diseases characterized by excessive proliferation of an inmature cellular clon. Depending of the myeloid or lymphoid origin of such clon, the acute leukemia could be classified in myeloid or lymphoid respectivement. However, there are cases of acute leukemias with mixed phenotype where immunologic markers of more than on elineage are present. In the patient of this report was founded a mixed immunophenotype pattern by flow cytometry and the entity was classified as acute hybrid lymphoid B/ mieloid leukemia. Basedon theinicial diagnostic of acutelymphoidleukemia, the molecular studydiscoveredthepresence of E2A-PBX1 fusion gen. That molecular anomaly is formed as consequence of a traslocation between the1 and 19 chromosomes. The patient, a child of 20 months, died 12 days afte rthe first clynic symptoms begining. E2A-PBX1 fusion gen is associated to unfavorable outcome, mainly because the severe damage at the central nervous system as in fact it occurred. Until it was possible review, no any similar report was founded about a case of acute hybrid lymphoidB/myeloid leukemia positive to the E2A-PBX1 fusion gen(AU)


Subject(s)
Humans , Male , Infant , Leukemia, Biphenotypic, Acute/complications , Leukemia, Biphenotypic, Acute/diagnosis , Leukemia, Biphenotypic, Acute/immunology , Case Reports , Leukemia, Biphenotypic, Acute/mortality
6.
Arch. Soc. Esp. Oftalmol ; 92(3): 145-148, mar. 2017. ilus
Article in Spanish | IBECS | ID: ibc-160966

ABSTRACT

CASO CLÍNCO:Mujer de 43 años con leucemia linfoblástica T en remisión completa, remitida por sospecha de necrosis retiniana herpética/retinitis leucémica en el ojo izquierdo (OI). La agudeza visual era de unidad y el fondo de ojo presentaba retinitis y hemorragias en periferia. Ante estudio hematológico negativo, recibió tratamiento por retinitis por citomegalovirus. Tras mejoría inicial, aparece papilitis en el OI y restricción de la motilidad en el ojo derecho. La resonancia y punción lumbar confirman la recidiva leucémica. DISCUSIÓN: La afectación ocular puede preceder a la recaída hematológica, por eso debe sospecharse ante sintomatología ocular. Además, son frecuentes las infecciones oportunistas en inmunodeprimidos


CLINICAL CASE: A 43-year-old woman in remission from T- cell acute lymphoblastic leukaemia was referred to our hospital with suspected leukaemic retinitis. The funduscopic examination of her left eye revealed multifocal yellow-white peripheral retinitis and retinal haemorrhage. The patient was treated for cytomegalovirus retinitis after an extended haematological investigation showed no abnormalities. Initial improvement was followed by papillitis in the left eye and motility restriction in the right eye. Magnetic resonance and lumbar puncture confirmed leukaemia relapse. Specific treatment was initiated with complete resolution. DISCUSSION: Ocular involvement may precede haematological leukaemia relapse. Physicians should be alerted when ocular symptoms appear in these cases


Subject(s)
Humans , Female , Adult , Cytomegalovirus Retinitis/complications , Cytomegalovirus Retinitis/diagnosis , Cytomegalovirus Retinitis/therapy , Papilledema/complications , Papilledema/diagnosis , Optic Nerve , Optic Nerve , Leukemia/complications , Leukemia, Biphenotypic, Acute/complications , Cytomegalovirus Retinitis/drug therapy , Cytomegalovirus Retinitis/radiotherapy
9.
Int J Hematol ; 103(5): 592-5, 2016 May.
Article in English | MEDLINE | ID: mdl-26879198

ABSTRACT

We report a case of Cyberlindnera fabianii fungemia after umbilical cord blood transplantation (CBT). A 69-year-old woman was diagnosed as having mixed phenotype acute leukemia. The patient received CBT for primary refractory disease. After preconditioning chemotherapy, the patient's condition deteriorated, leading to acute respiratory failure from capillary leak syndrome and consequent admittance to the intensive care unit. The patient recovered temporarily following the administration of noninvasive positive pressure ventilation and continuous hemodiafiltration, but died of fungemia with the presence of yeast-like cells 15 days post-CBT. The yeast-like cells were analyzed by sequencing of the D1/D2 domain of the large subunit and the internal transcribed spacer domain, and were identified as C. fabianii. This case shows that molecular genetic-based methods may be effective for detecting undetermined invasive fungal infections in stem cell transplantation settings.


Subject(s)
Fetal Blood/transplantation , Fungemia/etiology , Leukemia, Biphenotypic, Acute/complications , Leukemia, Biphenotypic, Acute/therapy , Pichia/isolation & purification , Aged , Antifungal Agents/therapeutic use , Cord Blood Stem Cell Transplantation/adverse effects , Female , Fungemia/diagnosis , Fungemia/drug therapy , Humans , Pichia/drug effects
11.
Medicine (Baltimore) ; 94(37): e1461, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26376384

ABSTRACT

Renal enlargement at time of diagnosis of acute leukemia is very unusual. We here in report 2 pediatric cases of acute leukemia who had their renal affection as the first presenting symptom with no evidences of blast cells in blood smear and none of classical presentation of acute leukemia. The first case is a 4-year-old girl who presented with pallor and abdominal enlargement. Magnetic resonance imaging showed bilateral symmetrical homogenous enlarged kidneys suggestive of infiltration. Complete blood picture (CBC) revealed white blood count 11 × 109/L, hemoglobin 8.7 g/dL and platelet count 197 × 109/L. Bone marrow aspiration was performed, and diagnosed precursor B-cell ALL was made. The child had an excellent response to modified CCG 1991 standard risk protocol of chemotherapy with sustained remission, but unfortunately relapsed 11 month after the end of therapy. The second child was 13-month old, presented with pallor, vomiting, abdominal enlargement, and oliguria 2 days before admission. Initial CBC showed bicytopenia, elevated blood urea, creatinine, and serum uric acid, while abdominal ultrasonography revealed bilateral renal enlargement. Bone marrow examination was done and showed 92% blast of biphenotypic nature. So, biphynotypic leukemia with bilateral renal enlargement and acute renal failure was subsequently diagnosed. The patients admitted to ICU and received supportive care and prednisolone. Renal function normalized and chemotherapy was started. The child achieved complete remission with marked reduction of kidney size but, unfortunately she died from sepsis in consolidation phase of therapy. This case demonstrates an unusual early renal enlargement in childhood acute leukemia. Renal involvement of acute leukemia should be considered in child presenting with unexplained bilateral renal enlargement with or without renal function abnormalities and bone marrow examination should be included in the workup.


Subject(s)
Kidney Diseases/etiology , Leukemia, Biphenotypic, Acute/complications , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/complications , Child, Preschool , Female , Humans , Infant , Kidney/pathology , Kidney Diseases/pathology , Leukemia, Biphenotypic, Acute/diagnosis , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/diagnosis
12.
Rev. iberoam. micol ; 32(1): 59-61, ene.-mar. 2015.
Article in Spanish | IBECS | ID: ibc-132899

ABSTRACT

Antecedentes. La tricosporonosis es una infección oportunista debida a hongos levaduriformes del género Trichosporon. La mayoría de los casos de tricosporonosis invasiva acontecen en individuos inmunodeficientes. Caso clínico. Describimos un caso de infección diseminada por Trichosporon asahii en un paciente hematológico. Se trata de un varón de 52 años diagnosticado de leucemia linfoblástica aguda que desarrolla un cuadro febril durante el tercer ciclo de quimioterapia de inducción. A las 24 h de incubación se observó positividad en los hemocultivos extraídos, visualizándose en la tinción de Gram estructuras alargadas compatibles con elementos fúngicos. La identificación del hongo como Trichosporon asahii se llevó a cabo mediante la asimilación de compuestos de carbono y la amplificación y secuenciación de los dominios D1/D2 y la región espaciadora interna transcrita del ADN ribosómico. El hongo se aisló además de unas lesiones pustulosas que presentaba el paciente en la región pectoral. Tras tratamiento con anfotericina B, el paciente evolucionó favorablemente de las lesiones y del proceso febril. Conclusiones. Trichosporon asahii es un patógeno emergente en pacientes inmunodeprimidos y su presencia no debe ser considerada como colonización, pues existe riesgo de infección invasiva (AU)


Background. Trichosporonosis is an opportunistic infection caused by the genus Trichosporon. The majority of cases of invasive trichosporonosis occurs in immunocompromised individuals. Case report. We describe a case of disseminated infection by Trichosporon asahii in a hematology patient. A 52-year-old man diagnosed with acute lymphoblastic leukemia developed a febrile episode during the third cycle of the induction chemotherapy. The blood cultures were positive after 24 h incubation, showing elongated structures compatible with fungal elements in the Gram stain. The identification of the fungus as Trichosporon asahii was carried out by the assimilation of compounds of carbon and the amplification and sequencing of the D1/D2 domain and the internal transcribed spacer of the ribosomal DNA. The fungus was also isolated from the pustular lesions that the patient had in the chest. After treatment with amphotericin B, the patient progressed satisfactorily. Conclusions. Trichosporon asahii is an emergent pathogen in immunosupressed patients and its presence should not be considered as colonization, as there is risk of invasive infection (AU)


Subject(s)
Humans , Male , Middle Aged , Fungemia/diagnosis , Fungemia/microbiology , Trichosporon/isolation & purification , Leukemia, Biphenotypic, Acute/complications , Leukemia, Biphenotypic, Acute/microbiology , Opportunistic Infections/complications , Opportunistic Infections/diagnosis , Opportunistic Infections/microbiology , Amphotericin B/metabolism , Amphotericin B/therapeutic use , Fever/complications , Fever/drug therapy , Fungemia/therapy , Fever/etiology
13.
Pediatr. aten. prim ; 16(64): 337-339, oct.-dic. 2014.
Article in Spanish | IBECS | ID: ibc-131216

ABSTRACT

La cojera o el dolor musculoesquelético es una consulta frecuente en la infancia. Su etiología es diversa y frecuentemente banal. En algunas ocasiones la cojera puede ser el síntoma inicial de procesos neoplásicos. Presentamos el caso de una lactante de 20 meses de edad que presentó una cojera de dos semanas de evolución. En la valoración inicial en Atención Primaria no se apreció patología de gravedad, se realizó una ecografía de caderas y fue diagnosticada de sinovitis transitoria. Tras un periodo de reposo relativo y antiinflamatorios no se apreció mejoría. Varias semanas después presentó dolor nocturno de extremidades de forma intermitente. Se realizó una analítica en la que se apreciaba una neutropenia. Ante la persistencia de la cojera, la presentación del dolor nocturno y la neutropenia, se procedió a derivar a la paciente al Servicio de Oncohematología de referencia donde se diagnosticó de leucemia linfoblástica aguda (AU)


Lameness or musculoskeletal pain is a frequent consultation in the infancy. Its etiology is diverse and frequently not severe. In some cases lameness can be the initial symptom of neoplasic processes. Caucasic woman aged 20 months who presented lameness of two weeks of evolution. In the initial evaluation in Health primary care center we didn't appreciate any severity process. An ultrasound scan of hips was realized and she was diagnosticated of transient sinovitis of the hip. After a period of relative rest and anti-inflammatory treatment medical staff didn't appreciate any improvement. Several weeks later she presented intermitent night pain in the legs. A blood sample was taken and discovered neutropaenia. Given the persistence of the lameness, night pain and neutropenia, paediatrician sent the patient to paediatric oncohematology department where the diagnosis of linfoblastic leukaemia was realized after bony marrow aspiration (AU)


Subject(s)
Humans , Female , Infant , Synovitis/complications , Synovitis/diagnosis , Musculoskeletal System/pathology , Musculoskeletal System , Neutropenia/complications , Neutropenia/diagnosis , Leukemia, Biphenotypic, Acute/complications , Leukemia, Biphenotypic, Acute/diagnosis , Ibuprofen/therapeutic use , Primary Health Care/methods , Primary Health Care/trends , Leukemia, Biphenotypic, Acute/drug therapy , Leukemia, Biphenotypic, Acute/physiopathology
14.
Turk J Pediatr ; 55(1): 42-9, 2013.
Article in English | MEDLINE | ID: mdl-23692831

ABSTRACT

The aim of this study was to evaluate the relationship between cerebrospinal fluid (CSF) osteopontin (OPN) levels and central nervous system (CNS) involvement in children with a diagnosis of acute leukemia. The study sample consisted of 62 patients who had been diagnosed with acute leukemia. The control group consisted of 16 patients that had presented and had no malignant disease, CNS infection or chronic disease. CSF OPN levels were studied with enzyme-linked immunosorbent assay (ELISA) method. The mean CSF OPN level was 32.76±49.22 ng/ml in the patients at the time of diagnosis and 14.93±6.84 ng/ml in the control group (p>0.05). The mean CSF OPN level was 27.68±32.73 ng/ml at the time of diagnosis in the group without CNS involvement and 53.48±89.21 ng/ml in the group with CNS involvement (p>0.05). However, the CSF OPN level at the time of CNS relapse in patients who developed CNS involvement during follow-up (127.4±52 ng/ml) was significantly higher than in the group without CNS involvement at diagnosis and follow-up (mean CSF OPN level: 27.68±32.73 ng/ml) (p<0.001). The analysis of CSF OPN levels at the time of diagnosis-before relapse and at the periods of relapse and remission in patients who had CNS involvement at diagnosis and/or follow-up revealed statistically significant differences between the time points (p<0.001). High CSF OPN levels in childhood acute leukemia patients may be used as evidence for CNS involvement, and any increases found in CSF OPN levels may be a preliminary predictor for CNS involvement.


Subject(s)
Central Nervous System Neoplasms/cerebrospinal fluid , Osteopontin/cerebrospinal fluid , Precursor Cell Lymphoblastic Leukemia-Lymphoma/cerebrospinal fluid , Acute Disease , Biomarkers/cerebrospinal fluid , Child , Child, Preschool , Female , Humans , Infant , Leukemia, Biphenotypic, Acute/cerebrospinal fluid , Leukemia, Biphenotypic, Acute/complications , Leukemia, Myeloid, Acute/cerebrospinal fluid , Leukemia, Myeloid, Acute/complications , Male , Neoplasm Proteins/cerebrospinal fluid , Precursor Cell Lymphoblastic Leukemia-Lymphoma/complications , Prospective Studies , Remission Induction
15.
Mycopathologia ; 175(1-2): 107-14, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23076561

ABSTRACT

Disseminated fusariosis has emerged as a significant, usually fatal infection in immunocompromised hosts despite antifungal treatment. We describe here two patients with acute leukemia who developed disseminated amphotericin-resistant fusariosis, and review of six studies of cases series in the literature. Two Fusarium solani strains were isolated from blood and skin cultures of one patient, and one strain from the blood culture of the second patient. Both patients died despite antifungal treatment. Strains were identified by sequencing of ITS1 and ITS4 regions. Random amplified polymorphic DNA analysis of the three F. solani isolates showed a low degree of similarity. Screening for Fusarium spp. contaminants within our facility was negative. Using the CLSI M-38-A2 broth dilution method and E tests(®), we found that the MICs were low for voriconazole (0.12 and 0.5 mg/L, respectively), unexpectedly high for amphotericin B (≥8 and ≥32 µg/mL, respectively) and itraconazole (≥16 mg/ml). Patients with leukemia or persistent neutropenia should be assessed for disseminated fungal infections, including biopsy and skin cultures. Antifungal susceptibility tests are important due to the possibility of the strains being amphotericin resistant. Treatments must be aggressive, with high doses of antifungals or combined therapy.


Subject(s)
Amphotericin B/pharmacology , Antifungal Agents/pharmacology , Fusariosis/diagnosis , Fusariosis/pathology , Fusarium/drug effects , Leukemia, Biphenotypic, Acute/complications , Precursor Cell Lymphoblastic Leukemia-Lymphoma/complications , Aged , DNA, Fungal/chemistry , DNA, Fungal/genetics , DNA, Ribosomal Spacer/chemistry , DNA, Ribosomal Spacer/genetics , Drug Resistance, Fungal , Fatal Outcome , Fusariosis/microbiology , Fusarium/isolation & purification , Humans , Male , Microbial Sensitivity Tests , Sequence Analysis, DNA
16.
Dermatol Online J ; 16(4): 5, 2010 Apr 15.
Article in English | MEDLINE | ID: mdl-20409412

ABSTRACT

Candida krusei is an emerging fungal pathogen found primarily in immunocompromised patients. Intrinsic resistance to fluconazole and decreasing susceptibility to other anti-fungal agents are problematic. When colonization occurs, dissemination may follow rapidly. We present a case of a patient with acute lymphoblastic leukemia who, despite being treated prophylactically with fluconazole, developed disseminated C. krusei.


Subject(s)
Candidiasis, Cutaneous/diagnosis , Candidiasis, Cutaneous/immunology , Fungemia/diagnosis , Fungemia/immunology , Immunocompromised Host , Leukemia, Biphenotypic, Acute/complications , Antifungal Agents/therapeutic use , Candida , Candidiasis, Cutaneous/prevention & control , Fluconazole/therapeutic use , Fungemia/prevention & control , Humans , Leukemia, Biphenotypic, Acute/immunology , Male , Young Adult
17.
Transpl Int ; 23(5): e1-4, 2010 May 01.
Article in English | MEDLINE | ID: mdl-20028495

ABSTRACT

A 30-year-old woman developed severe liver dysfunction 1 year after bone marrow transplantation (BMT) from an HLA-identical sibling donor for B lymphoblastic leukemia (B-ALL) during the tapering of cyclosporin A. The histologic picture resembled autoimmune hepatitis (AIH), although neither autoantibody nor hypergammaglobulinemia was detected. She entered hepatic coma, and underwent living donor liver transplantation from the same donor on day 421 after BMT. She is well 18 months after the procedure, showing normal liver function and hematopoiesis. AIH-like hepatic graft-versus-host disease (GVHD) has not been documented. This patient is the second case of living donor liver transplantation for hepatic GVHD from the same donor.


Subject(s)
Bone Marrow Transplantation/methods , Graft vs Host Disease/etiology , Hepatitis, Autoimmune/immunology , Liver Transplantation/methods , Living Donors , Adult , Biopsy , Female , Graft vs Host Disease/therapy , HLA Antigens/chemistry , Hematopoiesis , Hepatitis, Autoimmune/etiology , Humans , Hypergammaglobulinemia/immunology , Immunophenotyping , Immunosuppressive Agents/therapeutic use , Leukemia, Biphenotypic, Acute/complications , Leukemia, Biphenotypic, Acute/therapy
18.
Acta Med Okayama ; 63(4): 213-6, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19727206

ABSTRACT

A 23-year old woman with acute biphenotypic leukemia (ABL) complained of chest pain with cough, high fever and hemoptysis during induction chemotherapy, although she had been treated with anti-biotics and micafungin. We made a clinical diagnosis of invasive pulmonary aspergillosis (IPA) based on a consolidation in the right upper lung field on a chest radiograph as well as a high level of serum beta-D-glucan (with no evidence of tuberculosis and candidiasis). We changed her treatment from micafungin to voriconazole. Later, we discovered an air-crescent sign by CT scan that supported the diagnosis of IPA. Following voriconazole treatment, clinical symptoms ceased and abnormal chest shadows improved gradually and concurrently with a recovery of neutrophils. IPA must be considered in immunocompromised patients with pulmonary infiltrates who do not respond to broad-spectrum antibiotics. Serological tests and CT findings can aid in early diagnosis of IPA, which, along with treatment for IPA, will improve clinical outcomes.


Subject(s)
Antifungal Agents/therapeutic use , Invasive Pulmonary Aspergillosis/drug therapy , Leukemia, Biphenotypic, Acute/complications , Pyrimidines/therapeutic use , Triazoles/therapeutic use , Adult , Female , Humans , Invasive Pulmonary Aspergillosis/diagnosis , Tomography, X-Ray Computed , Voriconazole
19.
Biol Blood Marrow Transplant ; 15(1 Suppl): 79-83, 2009 Jan.
Article in English | MEDLINE | ID: mdl-19147083

ABSTRACT

Infants with leukemia who require hematopoietic cell transplantation (HCT) remain 1 of the most significant challenges in pediatric stem cell transplant. Infant leukemia is characterized by a unique biology including a predominance mixed lineage leukemia(MLL) gene rearrangement and juvenile myelomonocytic leukemia. Moreover, the long-term effects of transplantation are particularly prominent in infants who have active endocrine, cardiovascular, pulmonary, neurologic, musculoskeletal, hearing, and vision development, with the added risk of second malignant neoplasms. Currently, there is no solid basis to support allogeneic HCT as first-line therapy for infant acute lymphoblastic leukemia-first remission (ALL-CR1), although indicated for other infant leukemias, including juvenile myelomonocytic leukemia (JMML). The relative long-term toxicity of total body irridiation (TBI) versus non-TBI containing preparative regimens for HCT in infants remains controversial, with the differences, especially on neurocognitive function, unknown.


Subject(s)
Hematopoietic Stem Cell Transplantation/adverse effects , Leukemia/complications , Leukemia/therapy , Hematopoietic Stem Cell Transplantation/methods , Humans , Infant , Infant, Newborn , Leukemia, Biphenotypic, Acute/complications , Leukemia, Biphenotypic, Acute/therapy , Leukemia, Myelomonocytic, Juvenile/complications , Leukemia, Myelomonocytic, Juvenile/therapy , Transplantation, Homologous , Whole-Body Irradiation
20.
J Infect Chemother ; 14(5): 361-7, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18936889

ABSTRACT

We report a case of fulminant septicemia with Bacillus cereus resistant to carbapenem. A 33-year-old man was suffering from febrile neutropenia (FN) on day 15 after the start of remission-induction therapy for biphenotypic acute leukemia under gut decontamination with polymyxin B and nystatin. Meropenem, a carbapenem, was administered according to the guideline for FN. Two days later (on day 17), he complained of severe abdominal pain, lost consciousness, went into sudden cardiopulmonary arrest, and died. Autopsy showed multiple spots of hemorrhage and necrosis caused by bacterial plaque in the brain, lungs, and liver. B. cereus was isolated from a blood sample obtained in the morning on day 17 and it was after his death that the isolated B. cereus was revealed to be resistant to carbapenem. B. cereus obtained from blood samples has been reported to be usually sensitive to carbapenem and also to vancomycin, new quinolones, and clindamycin. If B. cereus resistant to carbapem increases, our method of gut decontamination with polymyxin B and nystatin may have to be changed to one containing a new quinolone for the prevention of septicemia. Careful watching to determine whether B. cereus resistant to carbapem increases may be also important for empiric therapy, because carbapenem is often selected as the initial therapy for FN in patients with severe neutropenia.


Subject(s)
Bacillus cereus/drug effects , Bacteremia/microbiology , Carbapenems/therapeutic use , Leukemia, Biphenotypic, Acute/complications , Adult , Anti-Bacterial Agents/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Bacillus cereus/isolation & purification , Bacteremia/complications , Bacteremia/diagnosis , Bacteremia/drug therapy , Brain Stem/microbiology , Brain Stem/pathology , Carbapenems/pharmacology , Fever/drug therapy , Gram-Positive Bacterial Infections/complications , Gram-Positive Bacterial Infections/diagnosis , Gram-Positive Bacterial Infections/drug therapy , Gram-Positive Bacterial Infections/pathology , Humans , Leukemia, Biphenotypic, Acute/diagnosis , Leukemia, Biphenotypic, Acute/drug therapy , Liver/microbiology , Liver/ultrastructure , Lung/microbiology , Lung/ultrastructure , Male , Microbial Sensitivity Tests , Neutropenia/drug therapy , Remission Induction , beta-Lactam Resistance
SELECTION OF CITATIONS
SEARCH DETAIL
...